
|Articles|January 1, 1996
Supplements and Featured Publications
- Advances in Cardiovascular Therapeutics: Trends in ACE Inhibition
- Volume 2
- Issue 1 Suppl
Do All Patients Deserve Treatment with Angiotensin Converting Enzyme Inhibitors after Myocardial Infarction? An Argument to Treat only High-Risk Patients
Author(s)Stephen G. Ball, PhD
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Aficamten for Obstructive Hypertrophic Cardiomyopathy
2
Fuzuloparib Monotherapy Improves PFS in Advanced Ovarian Cancer, but Adding Apatinib Offers No Additional Benefit
3
Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure
4
Top 5 Myasthenia Gravis Content of 2025
5







































